PENTOSE PHARMACEUTICALS INC has a total of 26 patent applications. Its first patent ever was published in 1996. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are ANTEROGEN CO LTD, AMCYTE INC and PRIMEGEN BIOTECH LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 9 | |
#2 | Canada | 6 | |
#3 | Australia | 3 | |
#4 | Israel | 2 | |
#5 | United States | 2 | |
#6 | Brazil | 1 | |
#7 | China | 1 | |
#8 | EPO (European Patent Office) | 1 | |
#9 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Organic fine chemistry | |
#5 | Environmental technology | |
#6 | Basic materials chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Budowsky Edward I | 18 |
#2 | Ackerman Samuel K | 17 |
#3 | Purmal Andrei A | 7 |
#4 | Edson Clark M | 3 |
#5 | Edson Clark Mcwhorter | 2 |
#6 | Budowsky E I | 1 |
#7 | Budowksy Edward I | 1 |
#8 | Ackerman S K | 1 |
#9 | Williams Martin D | 1 |
Publication | Filing date | Title |
---|---|---|
AU6497099A | Methods to selectively inactivate viruses in biological compositions | |
WO9831374A1 | Method of treating rhinoviral infections | |
US5891705A | Method for inactivating a virus | |
US5955446A | Method of treating herpes infections with 2',5'-oligoadenylate-2',3'-cyclophosphate compounds |